Semaglutide Day 1: What Actually Happens After Your First Dose

The starting dose of semaglutide is a tolerability dose: its job is to settle your system into the medicine, not to deliver immediate results.
Most side effects, if any appear at all, are gastrointestinal and tend to be mild on day 1 — nausea, a reduced appetite, or a slight feeling of fullness are the most commonly reported first impressions.
Semaglutide is a once-weekly injection (or, for Wegovy tablets, a once-daily oral medicine), day 1 is the beginning of a titration schedule that runs over several months.
Serious symptoms such as severe persistent stomach pain, signs of an allergic reaction, or sudden changes in vision require urgent medical attention from the very first dose.

Your first dose of semaglutide has been injected, or your first tablet swallowed, and now you're wondering whether you did it right and what comes next. On day 1, most people feel very little — the medicine works gradually, not immediately, and the 0.25mg starting dose is chosen specifically to help your body adjust rather than to produce rapid weight loss. This is a prescription-only medicine; a Wegovy overview explains the licensed indications and what clinical assessment involves before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Day 1 through to day 7: the honest picture of what semaglutide does and doesn't do straight away

The moment after you inject: what your body is actually doing

You've followed the instructions, pressed the pen against your thigh or abdomen, and heard the click. The medicine is in, and almost nothing dramatic happens. That's deliberate.

Semaglutide is a GLP-1 receptor agonist: it mimics a gut hormone that signals fullness to the brain, slows the rate at which your stomach empties, and, over time, recalibrates appetite. The key phrase is "over time." On day 1, the amount of semaglutide circulating in your body is very small. The 0.25mg first-step dose reaches its peak concentration roughly 24 to 72 hours after injection, and the steady state that produces meaningful appetite suppression builds over weeks of consistent dosing, not hours.

What some people do notice in the first day or two: a subtle heaviness after meals, food that doesn't appeal quite the way it normally would, or mild nausea if they ate a large or fatty meal close to injecting. Others feel nothing at all. Both responses are normal. If you're using Wegovy tablets, the same principle applies, the first 1.5mg daily dose is an adjustment phase, not a therapeutic threshold.

The semaglutide treatment page has a fuller breakdown of how the medicine's mechanism works across the full dosing schedule.

Side effects on day 1: what's common, what to watch for, and when to call for help

It's understandable to feel a little anxious sitting with a new prescription medicine in your system. That's worth saying plainly, because most people searching for "semaglutide day 1" are doing so from exactly that position.

The side effects most commonly reported early in treatment are gastrointestinal: nausea, loose stools, constipation, burping, or a general feeling of digestive unsettledness. On day 1 specifically, these tend to be mild if they appear at all, the starting dose is low enough that many people complete their first week without any GI disruption. Drinking plenty of water, eating smaller portions and avoiding very greasy food on injection day can help. The first week on semaglutide page covers practical strategies in more detail.

A smaller group of people notice fatigue or a mild headache in the first 24 hours. These usually pass without intervention.

The symptoms that should not be waited out: severe or persistent abdominal pain, particularly pain that spreads to the back (a potential sign of pancreatitis, flagged by the MHRA in a Yellow Card Drug Safety Update for GLP-1 medicines); any sign of a serious allergic reaction such as swelling, difficulty breathing, or a rash; or sudden vision changes. These warrant same-day medical contact, not a search engine.

Any suspected side effect (including unexpected reactions on day 1) can be reported through the MHRA's Yellow Card scheme, open to patients as well as healthcare professionals.

What day 1 tells you about the weeks ahead

The titration schedule for injectable semaglutide runs 0.25mg for four weeks, then 0.5mg, then 1.0mg, 1.7mg and finally 2.4mg, each step guided by your prescriber. Wegovy tablets follow their own ascending schedule from 1.5mg daily up to the 25mg maintenance dose, with at least a month at each level. Day 1 is the first rung, not the whole ladder.

Weight change in the first week is rarely significant and shouldn't be used as a measure of whether the medicine is working. The clinical trials that established semaglutide's effectiveness (including STEP 1, published in the New England Journal of Medicine, which found around 15% average body-weight reduction over 68 weeks at the 2.4mg maintenance dose) measured outcomes over more than a year, not a week.

What day 1 is genuinely useful for is observation: noticing how your body tolerates the injection technique, confirming you're comfortable with the process, and establishing the weekly habit. People who find an injection day and time that fit their routine (a Sunday evening, say, or a Monday morning before work) tend to find the schedule easier to sustain. If you want to understand how the experience typically shifts across the first few days, the day 2 experience and day 3 on semaglutide pages walk through what commonly changes.

For anyone weighing up whether injectable or oral semaglutide suits their life better, a comparison of the options is covered on the which semaglutide is best for weight loss page, and our prescribers are the right people to discuss the clinical fit, you can explore the process on the treatment options page. The Wegovy online prescription guide covers what a legitimate private prescription pathway looks like in practice, including what clinical checks are involved before any treatment is issued.

If anything about your first day's experience is causing concern, our clinical team is available seven days a week, aftercare doesn't start at week two.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions